MTVA METAVIA INC Product Launches 8-K Filing 2023 - Product Launch NeuroBo Pharmaceuticals announced the dosing of the first patient in its Phase 2a clinical trial for the treatment of NASH.Get access to all SEC 8-K filings of the METAVIA INC